Apoptosis mediated by the TNF-related cytokine and receptor families

Journal of Cellular Biochemistry

Volumn 60, Issue 1, 1996, Pages 47-55

  Ware, Carl F ^a   VanArsdale, Sammee ^a   VanArsdale, Todd L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Death domain; ring finger; serine kinase; signal transduction; T lymphocytes

Indexed keywords

CD40 ANTIGEN; FAS ANTIGEN; LYMPHOTOXIN; PROTEIN SERINE KINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CELLULAR DISTRIBUTION; GROWTH REGULATION; HUMAN; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; ZINC FINGERS;

EID: 0030048494     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19960101)60:1<47::AID-JCB8>3.0.CO;2-3     Document Type: Article

References (48)

1. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BE, Goeddel DV (1984): Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312:724-729.
2. Gray P, Aggarwal B, Benton C, Bringman T, Henzel W, Jarrett J, Leung D, Moffat B, Ng P, Svedersky L, Palladino M, Nedwin G (1984): Cloning and expression of the cDNA for human lymphotoxin: A lymphokine with tumor necrosis activity. Nature 312:721-724.
3. Smith CA, Davis T, Anderson D, Solam L, Beckmann M, Jerzy R, Dower SK, Cosman D, Goodwin RG (1990): A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019-1024.
4. Loetscher HE, Pan Y-C, Lahm W-H, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W (1990): Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61:351-359.
5. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ (1994): Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977-987.
6. Beutler B (1990): The complex regulation and biology of TNF (cachectin). Crit Rev Oncog 2:9-18.
7. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S (1994): The CD40 antigen and its ligand. Annu Rev Immunol 12:881-922.
8. Adachi M, Watanabe-Fukunaga R, Nagata S (1993): Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of Ipr mice. Proc Natl Acad Sci USA 90:1756-1760.
9. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S (1994): Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976.
10. Gooding LR (1992): Virus proteins that counteract host immune defenses. Cell 71:5-7.
11. Browning J, Ribolini A (1989): Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines. J Immunol 143:1859-1867.
12. Andrews JS, Berger AE, Ware CF (1990): Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes: TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma. J Immunol 144:2582-2591.
13. Androlewicz MJ, Browning JL, Ware CF (1992): Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J Biol Chem 267:2542-2547.
14. Browning JL, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow EP, Hession C, O'Brine-Greco B, Foley SF, Ware CF (1993): Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847-856.
15. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, Russell JH, Karr R, Chaplin DD (1994): Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703-706.
16. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwjatkowski D (1994): Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371:508-511.
17. Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet T, Weerawarna K (1994): Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370:218-220.
18. Ware CF, Crowe PD, Grayson MH, Androlewicz MJ, Browning JL (1992): Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J Immunol 149:3881-3888.
19. Goh CR, Loh CS, Porter AG (1991): Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin). Prot Eng 4:785-791.
20. Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W (1993): Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: Implications for TNF receptor activation. Cell 73:431-445.
21. Van Ostade X, Vandenabeele P, Everaerdt B, Loetscher H, Gentz R, Brockhaus M, Lesslauer W, Tavernier J, Brouckaert P, Fiers W (1993): Human TNF mutants with selective activity on the p55 receptor. Nature 361:266-269.
22. Crowe PD, VanArsdale TL, Walter BN, Dahms KM, Ware CF (1994): Production of lymphotoxin (LT alpha) and a soluble dimeric form of its receptor using the baculovirus expression system. J Immunol Methods 168:79-89.
23. Baens M, Chaffanet M, Cassiman JJ, van den Berghe H, Marynen P (1993): Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid. Genomics 16:214-218.
24. Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA (1994) : A lymphotoxin-beta-specific receptor. Science 264:707-710.
25. Smith CA, Farrah T, Goodwin RG (1994): The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959-962.
26. Ware CF, Crowe PD, VanArsdale TL, Andrews JL, Grayson MH, Jerzy R, Smith CA, Goodwin RG (1991): Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J Immunol 147:4229-4238.
27. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH (1993): Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178:2231-2235.
28. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV (1993): A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845-853.
29. Itoh N, Nagata S (1993): A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 268:10932-10937.
30. Wong GH, Goeddel DV (1994): Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol 152:1751-1755.
31. Tartaglia LA, Pennica D, Goeddel DV (1993): Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268:18542-18548.
32. Higuchi M, Aggarwal BB (1994): Differential roles of two types of the TNF receptor in TNF-induced cytotoxicity, DNA fragmentation, and differentiation. J Immunol 152:4017-4025.
33. Tartaglia LA, Goeddel DV, Reynolds C, Figari IS, Weber RF, Fendly BM, Palladino Jr. MA (1993): Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J Immunol 151:4637-4641.
34. Rothe M, Wong SC, Henzel WJ, Goeddel DV (1994): A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692.
35. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW (1993): Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
36. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H (1993): Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
37. Erickson SL, de Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N, Sheehan KC, Schreiber RD, Goeddel DV (1994): Decreased sensitivity to tumour necrosis factor but normal T cell development in TNF receptor-2-deficient mice. Nature 372-560-563.
38. Tartaglia LA, Goeddel DV (1992): Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor. J Biol Chem 267:4304-4307.
39. Sato T, Irie S, Reed JC (1995): A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett 358:113-118.
40. Hu HM, O'Rourke K, Boguski MS, Dixit VM (1994): A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem 269:30069.
41. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale TL, Ware CF, Kieff E (1995): The Epstein-Barr Virus transforming protein LMP1 engages signaling proteins-for the tumor necrosis factor receptor family. Cell 80:389-399.
42. Rothe M, Sarma V, Dixit V, Goeddel DV (1995): TRAF2-mediated activation of NFκB by TNF receptor 2 and CD40. Science 269:1424-1427.
43. Cleveland JL, Ihle JN (1995): Contenders in FasL/TNF death signaling. Cell 81:479-482.
44. Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer-Avni Y, Camonis JH, Wallach D (1995): Self-association of the "Death Domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J Biol Chem 270:387.
45. VanArsdale TL, Ware CF (1994): TNF receptor signal transduction: Ligand-dependent stimulation of a serine protein kinase activity associated with TNFR60. J Immunol 153:3043-3050.
46. Beyaert R, Fiers W (1994): Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. FEBS Lett 340:9-16.
47. Wiegmann K, Schütze S, Machleidt T, Witte D, Krönke M (1994): Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005-1015.
48. Martin SJ, Green DR (1995): Protease activation during apoptosis: death by a thousand cuts. Cell 82:349-352.